Clinical Trial

Communicating Uncertainties Associated With the Benefits and Risks of New Cancer Drugs

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 30, 2025 (before its estimated June 2025 completion). Its status may not reflect the trial's current state.
Summary
This nationally representative randomized survey of US adults will evaluate the effect of using brief statements to communicate different sources of uncertainty about the benefits and harms of new cancer drugs on participants' decisions and understanding.
Trial Details
NCT Number NCT06997185
Lead Sponsor London School of Economics and Political Science
Collaborators: Harvard Medical School / Harvard Pilgrim Health Care Institute
Conditions Cancer
Enrollment 3,000 participants
Start Date 2025-05-09
Primary Completion 2025-06 (estimated)
Study Completion 2025-06 (estimated)
Updated on ClinicalTrials.gov 2025-05-30